An HDAC1 and HDAC3 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MS-275

Item No. 13284

Technical Information
Formal Name
N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-carbamic acid, 3-pyridinylmethyl ester
CAS Number
209783-80-2
Synonyms
  • Entinostat
  • MS-27-275
  • SNDX-275
Molecular Formula
C21H20N4O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/mlEthanol: 2 mg/ml
λmax
204, 233, 299 nm
SMILES
O=C(NCC1=CC=C(C(NC2=C(N)C=CC=C2)=O)C=C1)OCC3=CC=CN=C3
InChi Code
InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)
InChi Key
INVTYAOGFAGBOE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    MS-275 is an inhibitor of histone deacetylase 1 (HDAC1) and HDAC3 (IC50s = 0.3 and 8 µM, respectively).1 It is selective for HDAC1 and HDAC3 over HDAC8 (IC50 = >100 µM). MS-275 decreases the proliferation of A2780 ovarian, Calu-3 lung, HL-60 promyeloblast leukemia, and K562 chronic myeloid leukemia (CML) cells (IC50s = 0.0415, 0.195, 0.212, and 0.589 µM, respectively). It induces cell cycle arrest at the G1 phase in A2780 cells when used at a concentration of 1 µM. MS-275 (49 mg/kg per day) decreases tumor volume and increases intratumoral histone H4 acetylation in an HT-29 colon cancer mouse xenograft model.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hu, E., Dul, E., Sung, C.M., et alIdentification of novel isoform-selective inhibitors within class I histone deacetylases. J. Pharmacol. Exp. Ther. 307(2), 720-728 (2003).